--- title: "Neutra (NTRR) stock listing, news and investor profile" url: "https://aibio.space/companies/neutra/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Neutra Corp. (OTC: NTRR), United States. The directory classifies it as Biotechnology. Listing facts, related biotech companies and news on aibio.space." --- NTRR Neutra Corp. OTC · United States # Neutra (NTRR) news Listings · 2024-12-12 ## [Neutra Corp. files Form 15 to end SEC reporting duties](https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/) The notice, dated December 11, 2024, lists 16 holders of record of its common stock. ## Latest Neutra news We have not published a story on Neutra yet. When there is news, it will appear here. ## Neutra at a glance - **Ticker**: NTRR - **Listing**: OTC - **Country**: United States - **Cash, Oct 31, 2023**: $692 ### Related companies - [Cabaletta Bio](https://aibio.space/companies/cabaletta-bio/) NASDAQ: CABA - [Inhibrx Biosciences](https://aibio.space/companies/inhibrx-biosciences/) NASDAQ: INBX - [Imunon](https://aibio.space/companies/imunon/) NASDAQ: IMNN - [Nuvation Bio](https://aibio.space/companies/nuvation-bio/) NYSE: NUVB - [Enliven Therapeutics](https://aibio.space/companies/enliven-therapeutics/) NASDAQ: ELVN - [Atrium Therapeutics](https://aibio.space/companies/atrium-therapeutics/) NASDAQ: RNA - [Enzolytics](https://aibio.space/companies/enzolytics/) OTC: ENZC - [Nkarta](https://aibio.space/companies/nkarta/) NASDAQ: NKTX ### Also on OTC - [CLARITAS PHARMACEUTICALS INC.](https://aibio.space/companies/claritas-pharmaceuticals/) CLAZF - [Cresco Labs](https://aibio.space/companies/cresco-labs/) CRLBF - [Syros Pharmaceuticals](https://aibio.space/companies/syros-pharmaceuticals/) SYRS - [ZyVersa Therapeutics](https://aibio.space/companies/zyversa-therapeutics/) ZVSA - [Scorpius Holdings](https://aibio.space/companies/scorpius/) SCPX - [InVitro International](https://aibio.space/companies/invitro-international/) IVRO ## Neutra annual financials | Line | FY ended Jan 31, 2023 | FY ended Jan 31, 2022 | |---|---|---| | Revenue | [$67,996](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | [$92,014](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | | Net income (loss) | [-$561,417](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | [-$632,926](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | | Cash from operations | [-$153,243](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | [-$405,615](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | | Cash and equivalents | [$1,969](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000627/) | [$1,056](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/) | Latest balance sheet, Oct 31, 2023 (10-Q): cash and equivalents $692. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Neutra What is the ticker symbol of Neutra? Neutra Corp. trades under the ticker NTRR on OTC. Where is Neutra listed? Neutra Corp. is listed on OTC. What is the SEC CIK of Neutra? The SEC Central Index Key (CIK) for Neutra Corp. is 1512886. Its filings are on SEC EDGAR. How many shares does Neutra have outstanding? 2,917,899,124 shares as of 2023-12-15, per the cover page of its 10-Q filed 2023-12-15. Which country or territory is Neutra listed under? Our directory records Neutra Corp. under United States. What does Neutra do? Our directory classifies Neutra Corp. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Neutra? The ISIN recorded for Neutra Corp. is US64129C3034. Does aibio.space cover Neutra? aibio.space lists Neutra Corp. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Neutra incorporated? SEC records list its state or country of incorporation as WY. What was Neutra's revenue last year? $67,996 for the fiscal year ended Jan 31, 2023, as reported to the SEC. Is Neutra profitable? Neutra Corp. reported a net loss of $561,417 for the fiscal year ended Jan 31, 2023, and used $153,243 of cash in operations, per its annual report to the SEC. How much cash does Neutra have? $692 in cash at Oct 31, 2023, per its 10-Q. What is the latest Neutra (NTRR) stock news? Our latest story on Neutra, dated Dec 12, 2024: "Neutra Corp. files Form 15 to end SEC reporting duties". The notice, dated December 11, 2024, lists 16 holders of record of its common stock. [Source](https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/). Is Neutra at risk of delisting? Our latest listing story, dated Dec 12, 2024: "Neutra Corp. files Form 15 to end SEC reporting duties". The notice, dated December 11, 2024, lists 16 holders of record of its common stock. [Source](https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/). Is Neutra a smaller reporting company? SEC records list Neutra Corp.'s filer category as: Non-accelerated filer
Smaller reporting company. ## Investor discussion: Neutra Members talk about Neutra (NTRR). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Neutra, newest first. Each line links the filing it comes from. 1. 2024-12-12 Listings Filed to end its SEC reporting. SEC Form 15-12G. [Source](https://www.sec.gov/Archives/edgar/data/1512886/000116169724000513/form_15.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:NTRR on TradingView](https://www.tradingview.com/symbols/OTC-NTRR/). ## SEC filings and registration - **SEC name**: Neutra Corp. - **CIK**: 1512886 - **Industry (SIC)**: Medicinal Chemicals & Botanical Products (2833) - **US tickers**: NTRR (OTC) - **State or country of incorporation**: WY - **Fiscal year ends**: January 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 2500 CITYWEST BLVD., HOUSTON, TX, 77042 - **Phone**: (307) 228-1488 - **Shares outstanding**: 2,917,899,124 as of 2023-12-15 (10-Q filed 2023-12-15) ### Recent filings (8-K and 6-K are the company's own announcements) - [10-Q](https://www.sec.gov/Archives/edgar/data/1512886/000116169724000330/form_10-q.htm) filed 2024-08-07 - [10-K](https://www.sec.gov/Archives/edgar/data/1512886/000116169724000323/form_10-k.htm) filed 2024-08-02 - [8-K](https://www.sec.gov/Archives/edgar/data/1512886/000116169724000233/form_8-k.htm) filed 2024-05-15 - [10-Q](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000627/form_10-q.htm) filed 2023-12-15 - [10-Q](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000485/form_10-q.htm) filed 2023-09-14 - [8-K](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000433/form_8-k.htm) filed 2023-08-04 - [10-Q](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000369/form_10-q.htm) filed 2023-06-22 - [10-K](https://www.sec.gov/Archives/edgar/data/1512886/000116169723000341/form_10-k.htm) filed 2023-06-09 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001512886), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Neutra Corp. is a public biotech or pharmaceutical company listed on OTC under the ticker NTRR, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Neutra Corp. - **Ticker**: NTRR - **Listing**: OTC - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US64129C3034 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/OTC-NTRR/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/neutra/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Neutra (NTRR) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/neutra/